by Sharon Rondeau

(Nov. 22, 2021) — According to Bloomberg followed by other reports, White House “Vaccinations Coordinator” Dr. Bechara Choucair, MD will leave his post today.

“Choucair’s last day will be Monday,” Bloomberg reported Sunday evening. “He joined President Joe Biden’s team during the transition last year and was charged with accelerating the nascent Covid-19 vaccination effort Biden inherited upon taking office in January.”

In an interview on November 16, 2021, Chocair told WSFA Channel 12 that “progress” was being made in the regime’s goal of vaccinating as many Americans as possible against COVID-19. Observed among the adult cohort, Chocair said, were “nearly 275,000 people in this country rolling up their sleeve and getting vaccinated for the first shot every single day.”

On September 9, Biden announced a mandate, which was immediately challenged and then stayed by the Fifth Circuit Court of Appeals, to impose COVID-19 vaccines on all federal agencies and companies with 100 or more employees, with an option for weekly testing at an employee’s expense.

“So we are making progress; we have to celebrate that,” Chocair’s interview continued. “At the same time, we have to make sure that we’re doing everything we can to reach those who are unvaccinated, having those conversations and getting them protected so we can celebrate the holidays even better this year.”

“A lot more people vaccinated” continues to be the goal, Chocair said.

As to the legal “challenges” to Biden’s mandate, Chocair responded, “Well, look, we know that vaccine requirements work; we’ve seen it over the last few months. We have thousands and thousands of businesses, healthcare organizations, universities put these vaccine requirements, and they’ve all got so many more people vaccinated…”

Chocair said he viewed prescription drugs in the form of “pills” currently under FDA evaluation for the treatment of COVID-19 as “encouraging.” However, he said, the better option is “our three safe and effective vaccines,” due to their preventive nature.

The CDC, too, says the vaccines are “safe and effective” despite mounting evidence to the contrary.

NIAID Director Dr. Anthony S. Felty, who has been the face of the coronavirus pandemic since it was declared in March 2020, recently admitted in a November 12, 2021 New York Times interview that the COVID-19 vaccines do not prevent infection, transmission, or even hospitalization, the outcome of which for many is death. His statement came months after after CDC Director Dr. Rochelle Walensky admitted that vaccinated individuals are equally capable of transmitting COVID-19 as their unvaccinated counterparts.

The interviewer did not challenge Chocair on his assertions in light of the fact that Fauci’s New York Times interview occurred four days prior.

On Sunday, The Wall Street Journal reported that, “Breakthrough cases of Covid-19 are hitting older people and those with underlying health conditions particularly hard, according to a new review of data by The Wall Street Journal that sharpens the picture of who remains at risk despite vaccinations.”

Elaborating on the article, PennLive reported Monday:

It (The WSJ) found more than 1.89 million breakthrough cases, resulting in at least 72,000 hospitalizations and 20,000 deaths in the United States in 2021.

The journal attributed the rising number of breakthroughs to more people being vaccinated and the to immunity wearing off among people who got vaccinated many months ago.

It said the breakthrough cases show the need for booster shots.

The mainstream media has presented virtually no coverage of the hundreds of thousands of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS) since the U.S. vaccine rollout began late last year, which includes nearly 19,000 deaths through November 12.

Based on a 2011 study conducted by Harvard Pilgrim Research, between 1% and 10% of adverse events possibly connected to vaccines is entered into VAERS.

The CDC has acknowledged that myocarditis and pericarditis appear to be connected with the Pfizer and Moderna vaccines, “particularly in adolescents and young adults.”

“The vaccination challenge shifted during his tenure,” Bloomberg additionally wrote. “What started as an operational problem to get scarce supplies to priority groups evolved in the spring to a persuasion campaign to convince hesitant parts of the public to get the shots.”

 

Join the Conversation

1 Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.